| Symbol | BIO |
|---|---|
| Name | BIO-RAD LABORATORIES, INC. |
| Sector | INDUSTRIALS |
| Region | North America |
| Industry | Biotechnology: Laboratory Analytical Instruments |
| Address | 1000 ALFRED NOBEL DRIVE, HERCULES, California, 94547, United States |
| Telephone | +1 510 724-7000 |
| Fax | — |
| — | |
| Website | https://www.bio-rad.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier. Additional info from NASDAQ: |
Lakkaraju Roop Kalyan 🟡 adjusted position in 420 shares (1 derivative) of BIO-RAD LABORATORIES, INC. (BIO BIO.B) at $287.84 Transaction Date: Apr 24, 2026 | Filing ID: 000002
Read moreENLOE COURTNEY C 🟡 adjusted position in 77 shares (1 derivative) of BIO-RAD LABORATORIES, INC. (BIO BIO.B) at $287.84 Transaction Date: Apr 24, 2026 | Filing ID: 000002
Read more(99% Neutral) BIO-RAD LABORATORIES, INC. (BIO) Announces New Board Appointment
Read moreDirector Hinckley Greg K 🟡 adjusted position in 369 shares (2 derivative) of BIO-RAD LABORATORIES, INC. (BIO BIO.B) Transaction Date: Apr 21, 2026 | Filing ID: 000003
Read moreDirector PEI MELINDA LITHERLAND 🟡 adjusted position in 369 shares (2 derivative) of BIO-RAD LABORATORIES, INC. (BIO BIO.B) Transaction Date: Apr 21, 2026 | Filing ID: 000002
Read moreDirector EDWARDS JEFFREY L 🟡 adjusted position in 369 shares (2 derivative) of BIO-RAD LABORATORIES, INC. (BIO BIO.B) Transaction Date: Apr 21, 2026 | Filing ID: 000002
Read moreDirector PINKSTON ARNOLD A 🟡 adjusted position in 369 shares (2 derivative) of BIO-RAD LABORATORIES, INC. (BIO BIO.B) Transaction Date: Apr 21, 2026 | Filing ID: 000002
Read moreBio-Rad - Bio-Rad to Report First-Quarter 2026 Financial Results on Thursday, April 30, 2026
Read moreBio-Rad to Report First-Quarter 2026 Financial Results on Thursday, April 30, 2026
Read moreNew Form SCHEDULE 13G/A - BIO-RAD LABORATORIES, INC. <b>Filed:</b> 2026-03-26 <b>AccNo:</b> 0000102909-26-000749 <b>Size:</b> 7 KB
Read more